The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

BACKGROUND: Valproate is widely accepted as a drug of first choice for patients with generalised onset seizures, and its broad spectrum of efficacy means it is recommended for patients with seizures that are difficult to classify. Lamotrigine and topiramate are also thought to possess broad spectrum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marson, Anthony G, Al-Kharusi, Asya M, Alwaidh, Muna, Appleton, Richard, Baker, Gus A, Chadwick, David W, Cramp, Celia, Cockerell, Oliver C, Cooper, Paul N, Doughty, Julie, Eaton, Barbara, Gamble, Carrol, Goulding, Peter J, Howell, Stephen J L, Hughes, Adrian, Jackson, Margaret, Jacoby, Ann, Kellett, Mark, Lawson, Geoffrey R, Leach, John Paul, Nicolaides, Paola, Roberts, Richard, Shackley, Phil, Shen, Jing, Smith, David F, Smith, Philip E M, Smith, Catrin Tudur, Vanoli, Alessandr a, Williamson, Paula R
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2039891/
https://ncbi.nlm.nih.gov/pubmed/17382828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(07)60461-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados